AR103414A1 - Derivados de hidroxialquil-piperazina como moduladores del receptor cxcr3 - Google Patents
Derivados de hidroxialquil-piperazina como moduladores del receptor cxcr3Info
- Publication number
- AR103414A1 AR103414A1 ARP160100086A ARP160100086A AR103414A1 AR 103414 A1 AR103414 A1 AR 103414A1 AR P160100086 A ARP160100086 A AR P160100086A AR P160100086 A ARP160100086 A AR P160100086A AR 103414 A1 AR103414 A1 AR 103414A1
- Authority
- AR
- Argentina
- Prior art keywords
- heteroaryl
- alkyl
- alkoxy
- cxcr3
- hydroxialquil
- Prior art date
Links
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 title 1
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229910052717 sulfur Chemical group 0.000 abstract 2
- 239000011593 sulfur Chemical group 0.000 abstract 2
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 108010061300 CXCR3 Receptors Proteins 0.000 abstract 1
- 102000011963 CXCR3 Receptors Human genes 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Sales farmacéuticamente aceptables de los mismos y al uso de dichos compuestos como medicamentos, especialmente como moduladores del receptor CXCR3. Reivindicación 1: Un compuesto de fórmula (1), en donde n representa el número entero 1 ó 2; X representa N o CH; R¹ representa heteroarilo, en donde el heteroarilo es un anillo aromático monocíclico o bicíclico de 5 a 10 miembros que contiene 1, 2 ó 3 heteroátomos seleccionados de manera independiente de oxígeno, nitrógeno y azufre, y en donde el heteroarilo está, de manera independiente, no sustituido o mono- o di-sustituido, en donde los sustituyentes se seleccionan, de manera independiente, del grupo integrado por alquilo C₁₋₄, cicloalquilo C₃₋₆, alcoxi C₁₋₄, alcoxi C₁₋₂-alquilo C₁₋₂, alquilo C₁₋₂-carbonilo, hidroxi-alquilo C₁₋₄, halógeno, fluoroalquilo C₁₋₂, fenilo y heteroarilo, en donde el heteroarilo es un anillo aromático monocíclico de 5 ó 6 miembros que contiene 1, 2 ó 3 heteroátomos seleccionados de manera independiente de oxígeno, nitrógeno y azufre, y en donde el heteroarilo está, de manera independiente, no sustituido o mono-sustituido con alquilo C₁₋₄; y R² representa cicloalquilo C₃₋₆, alcoxi C₁₋₄ o fluoroalquilo C₁₋₂; o una sal del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2015050696 | 2015-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR103414A1 true AR103414A1 (es) | 2017-05-10 |
Family
ID=55129886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160100086A AR103414A1 (es) | 2015-01-15 | 2016-01-14 | Derivados de hidroxialquil-piperazina como moduladores del receptor cxcr3 |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US10053457B2 (es) |
| EP (1) | EP3245203B1 (es) |
| JP (1) | JP6337218B2 (es) |
| KR (1) | KR101967083B1 (es) |
| CN (1) | CN107250133B (es) |
| AR (1) | AR103414A1 (es) |
| AU (1) | AU2016207988B2 (es) |
| BR (1) | BR112017015093A2 (es) |
| CA (1) | CA2972952C (es) |
| CL (1) | CL2017001831A1 (es) |
| CO (1) | CO2017008156A2 (es) |
| CY (1) | CY1121361T1 (es) |
| DK (1) | DK3245203T3 (es) |
| EA (1) | EA032927B1 (es) |
| ES (1) | ES2709985T3 (es) |
| HK (1) | HK1246789B (es) |
| HR (1) | HRP20190024T1 (es) |
| HU (1) | HUE042559T2 (es) |
| IL (1) | IL253411B (es) |
| LT (1) | LT3245203T (es) |
| MA (1) | MA41337A (es) |
| MX (1) | MX2017009288A (es) |
| MY (1) | MY187614A (es) |
| NZ (1) | NZ734542A (es) |
| PE (1) | PE20171100A1 (es) |
| PH (1) | PH12017501280B1 (es) |
| PL (1) | PL3245203T3 (es) |
| PT (1) | PT3245203T (es) |
| RS (1) | RS58349B1 (es) |
| SA (1) | SA517381905B1 (es) |
| SG (1) | SG11201705617XA (es) |
| SI (1) | SI3245203T1 (es) |
| TN (1) | TN2017000278A1 (es) |
| TR (1) | TR201900680T4 (es) |
| TW (1) | TWI693221B (es) |
| UA (1) | UA119805C2 (es) |
| WO (1) | WO2016113344A1 (es) |
| ZA (1) | ZA201705486B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA030067B1 (ru) | 2013-07-22 | 2018-06-29 | Идорсиа Фармасьютиклз Лтд | Производные 1-(пиперазин-1-ил)-2-([1,2,4]триазол-1-ил)этанона |
| AR099789A1 (es) | 2014-03-24 | 2016-08-17 | Actelion Pharmaceuticals Ltd | Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina |
| AR103399A1 (es) | 2015-01-15 | 2017-05-10 | Actelion Pharmaceuticals Ltd | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3 |
| AU2016207988B2 (en) * | 2015-01-15 | 2019-08-15 | Idorsia Pharmaceuticals Ltd | Hydroxyalkyl-piperazine derivatives as CXCR3 receptor modulators |
| WO2018011265A1 (en) * | 2016-07-13 | 2018-01-18 | Idorsia Pharmaceuticals Ltd | Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators |
| WO2020060964A1 (en) * | 2018-09-18 | 2020-03-26 | Alxerion Biotech Corp. | 1, 2, 4-oxadiazole derivatives and uses thereof |
| WO2022162017A1 (en) | 2021-01-28 | 2022-08-04 | Idorsia Pharmaceuticals Ltd | Crystalline form of a piperazinyl-thiazole derivative |
| WO2024052445A1 (en) | 2022-09-09 | 2024-03-14 | Idorsia Pharmaceuticals Ltd | Pharmaceutical combination comprising an anti-cd3 antibody and a cxcr3 antagonist |
Family Cites Families (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004523529A (ja) | 2001-01-23 | 2004-08-05 | イーライ・リリー・アンド・カンパニー | メラノコルチンレセプターアゴニスト |
| CA2433025A1 (en) | 2001-01-23 | 2002-08-01 | Chaoyu Xie | Substituted piperidines/piperazines as melanocortin receptor agonists |
| HUP0303484A2 (hu) | 2001-03-02 | 2004-01-28 | Bristol-Myers Squibb Company | Melanokortin receptor modulátoraiként hasznos vegyületek és a vegyületeket tartalmazó gyógyszerkészítmények |
| DE60328690D1 (de) | 2002-06-12 | 2009-09-17 | Chemocentryx Inc | 1-aryl-4-substituierte piperazin-derivate zur verwendung als ccr1-antagonisten zur behandlung von entzündungen und immunerkrankungen |
| US7589199B2 (en) | 2002-06-12 | 2009-09-15 | Chemocentryx, Inc. | Substituted piperazines |
| US7842693B2 (en) | 2002-06-12 | 2010-11-30 | Chemocentryx, Inc. | Substituted piperazines |
| US20050256130A1 (en) | 2002-06-12 | 2005-11-17 | Chemocentryx, Inc. | Substituted piperazines |
| GB0315203D0 (en) | 2003-06-28 | 2003-08-06 | Celltech R&D Ltd | Chemical compounds |
| WO2005035534A1 (ja) | 2003-10-08 | 2005-04-21 | Ono Pharmaceutical Co., Ltd. | 複素ビシクロ環および複素トリシクロ環化合物およびその医薬 |
| US20050124625A1 (en) | 2003-10-21 | 2005-06-09 | Salvati Mark E. | Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
| WO2005042516A2 (en) | 2003-10-22 | 2005-05-12 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
| GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
| CN102786482A (zh) | 2003-11-21 | 2012-11-21 | 阿雷生物药品公司 | Akt蛋白激酶抑制剂 |
| US20060276465A1 (en) | 2003-12-26 | 2006-12-07 | Eisai R&D Management Co., Ltd. | 1,2-di(cyclic) substituted benzene compounds |
| MY140489A (en) | 2003-12-26 | 2009-12-31 | Eisai R&D Man Co Ltd | 1,2-di (cyclic) substituted benzene compounds |
| JP5046950B2 (ja) | 2004-10-22 | 2012-10-10 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｃ−ｆｍｓキナーゼのインヒビター |
| US7645755B2 (en) | 2004-10-22 | 2010-01-12 | Janssen Pharmaceutical N.V. | Inhibitors of c-fms kinase |
| MX2007010067A (es) | 2005-02-16 | 2007-12-07 | Schering Corp | Compuestos heterociclicos novedosos sustituidos con piridina o fenilo con actividad antagonista de cxcr3. |
| EP1858888B1 (en) | 2005-02-16 | 2013-04-17 | Merck Sharp & Dohme Corp. | Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| US7566718B2 (en) | 2005-02-16 | 2009-07-28 | Schering Corporation | Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| CA2598458A1 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| MX2007009945A (es) | 2005-02-16 | 2007-09-26 | Schering Corp | Piperazinas sustituidas con heterociclicos con actividad antagonista de cxcr3. |
| CA2598489A1 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Piperazine-piperidines with cxcr3 antagonist activity |
| US7776862B2 (en) | 2005-02-16 | 2010-08-17 | Schering Corporation | Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| US7777035B2 (en) | 2005-06-22 | 2010-08-17 | Chemocentryx, Inc. | Azaindazole compounds and methods of use |
| PT1906965E (pt) | 2005-06-22 | 2015-09-03 | Chemocentryx Inc | Compostos de azaindazol e métodos de utilização |
| US20080312215A1 (en) | 2005-06-28 | 2008-12-18 | Pharmacopeia Drug Discovery, Inc. | Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders |
| US7754724B2 (en) | 2005-06-30 | 2010-07-13 | Dow Agrosciences Llc | N-substituted piperazines |
| TW200738701A (en) | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
| ATE546445T1 (de) | 2005-10-11 | 2012-03-15 | Schering Corp | Substituierte heterocyclische verbindungen mit cxcr3-antagonistischer wirkung |
| NZ595182A (en) | 2005-10-18 | 2012-12-21 | Janssen Pharmaceutica Nv | Pharmaceutical uses of 4-cyano-1H-imidazole-2-carboxylic acid { 2-cyclohex-1-enyl-4-[1-(2-dimethylamino-acetyl)-piperidin-4-yl]-phenyl} -amide |
| US20090143413A1 (en) | 2005-11-29 | 2009-06-04 | Adams Alan D | Thiazole Derivatives as CXCR3 Receptor Modulators |
| US20070126158A1 (en) | 2005-12-01 | 2007-06-07 | 3M Innovative Properties Company | Method of cleaning polymeric mold |
| WO2007070433A2 (en) * | 2005-12-12 | 2007-06-21 | Merck & Co., Inc. | 2-arylthiazole derivatives as cxcr3 receptor modulators |
| WO2007076318A2 (en) | 2005-12-21 | 2007-07-05 | Smithkline Beecham Corporation | Camphor-derived cxcr3 antagonists |
| EP1988900A2 (en) | 2006-02-23 | 2008-11-12 | Merck & Co., Inc. | Pyridine, pyrimidine and pyrazine derivatives as cxcr3 receptor modulators |
| MX2008012161A (es) | 2006-03-21 | 2008-10-03 | Schering Corp | Compuestos heterociclicos de piridina sustituida con actividad antagonista de cxcr3. |
| MX2008013528A (es) | 2006-04-20 | 2008-10-29 | Jannsen Pharmaceutica N V | Metodo para inhibir la cinasa del c-kit. |
| US7807671B2 (en) | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
| FR2903405B1 (fr) | 2006-07-04 | 2011-09-09 | Pasteur Institut | Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications |
| EP2041117B1 (en) | 2006-07-14 | 2012-08-22 | Merck Sharp & Dohme Corp. | Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| WO2008013622A2 (en) | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| WO2008079279A1 (en) | 2006-12-22 | 2008-07-03 | Schering Corporation | Heterocyclic compounds with cxcr3 antagonist activity |
| WO2008091594A2 (en) | 2007-01-24 | 2008-07-31 | E. I. Du Pont De Nemours And Company | Fungicidal mixtures |
| BRPI0806214A2 (pt) | 2007-01-25 | 2011-08-30 | Du Pont | composto, método para o controla das doenças vegetais causadas por patogenos vegetais fúngicos oomycete e composições fungicidas |
| WO2009020534A2 (en) | 2007-08-03 | 2009-02-12 | Schering Corporation | Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
| TWI428091B (zh) | 2007-10-23 | 2014-03-01 | Du Pont | 殺真菌劑混合物 |
| EP2234971A1 (en) | 2007-12-18 | 2010-10-06 | Schering Corporation | Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity |
| AU2009206522B2 (en) | 2008-01-25 | 2013-12-19 | E. I. Du Pont De Nemours And Company | Fungicidal amides |
| KR20150065958A (ko) | 2008-01-25 | 2015-06-15 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 살균제 복소환 화합물 |
| PE20091576A1 (es) | 2008-02-19 | 2009-11-05 | Sanofi Aventis | DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3 |
| WO2009132785A1 (de) | 2008-04-30 | 2009-11-05 | Bayer Cropscience Aktiengesellschaft | Thiazol-4-carbonsäureester und thioester als pflanzenschutzmittel |
| MX2011003151A (es) | 2008-10-01 | 2011-04-27 | Bayer Cropscience Ag | Tiazoles sustituidos con heterociclilo como agentes fitosanitarios. |
| KR101052065B1 (ko) | 2008-10-15 | 2011-07-27 | 한국과학기술연구원 | 칼슘이온 채널 조절제로서 유효한 피라졸릴메틸아민-피페라진 유도체와 이의 제조방법 |
| ES2452299T3 (es) | 2008-12-02 | 2014-03-31 | E. I. Du Pont De Nemours And Company | Compuestos heterocíclicos fungicidas |
| EP2376487B1 (de) | 2008-12-11 | 2016-01-06 | Bayer Intellectual Property GmbH | Thiazolyoximether und -hydrazone als pflanzenschutzmittel |
| WO2010126811A1 (en) | 2009-04-27 | 2010-11-04 | Boehringer Ingelheim International Gmbh | Cxcr3 receptor antagonists |
| US8362249B2 (en) | 2009-04-27 | 2013-01-29 | Boehringer Ingelheim International Gmbh | CXCR3 receptor antagonists |
| EP2272846A1 (de) | 2009-06-23 | 2011-01-12 | Bayer CropScience AG | Thiazolylpiperidin Derivate als Fungizide |
| JP2013501744A (ja) | 2009-08-12 | 2013-01-17 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | 殺微生物複素環 |
| UA107938C2 (en) | 2009-08-12 | 2015-03-10 | Syngenta Participations Ag | Heterocycles with microbicidal properties |
| WO2011051243A1 (en) | 2009-10-29 | 2011-05-05 | Bayer Cropscience Ag | Active compound combinations |
| CN102712634B (zh) | 2009-10-30 | 2016-04-06 | 拜耳知识产权有限责任公司 | 杂芳基哌啶和杂芳基哌嗪衍生物 |
| ES2553620T3 (es) | 2009-12-21 | 2015-12-10 | Bayer Cropscience Ag | Bis(difluorometil)pirazoles como fungicidas |
| US8952004B2 (en) | 2010-01-07 | 2015-02-10 | Boehringer Ingelheim International Gmbh | CXCR3 receptor antagonists |
| BR112012027762B1 (pt) | 2010-04-28 | 2018-06-05 | Bayer Intellectual Property Gmbh | Derivados de cetoheteroarilpiperidina e - piperazina como fungicidas |
| US8815775B2 (en) | 2010-05-18 | 2014-08-26 | Bayer Cropscience Ag | Bis(difluoromethyl)pyrazoles as fungicides |
| EP2571866A1 (en) | 2010-05-20 | 2013-03-27 | E.I. Du Pont De Nemours And Company | Fungicidal oximes and hydrazones |
| JP2013528169A (ja) | 2010-05-27 | 2013-07-08 | バイエル・クロップサイエンス・アーゲー | 殺菌剤としてのピリジニルカルボン酸誘導体 |
| US20120122928A1 (en) | 2010-08-11 | 2012-05-17 | Bayer Cropscience Ag | Heteroarylpiperidine and -Piperazine Derivatives as Fungicides |
| US8759527B2 (en) | 2010-08-25 | 2014-06-24 | Bayer Cropscience Ag | Heteroarylpiperidine and -piperazine derivatives as fungicides |
| EP2632922B1 (de) | 2010-10-27 | 2019-02-27 | Bayer CropScience Aktiengesellschaft | Heteroarylpiperidin und -piperazinderivate als fungizide |
| CN103228645A (zh) | 2010-11-25 | 2013-07-31 | 先正达参股股份有限公司 | 杀微生物杂环 |
| WO2012082580A2 (en) | 2010-12-17 | 2012-06-21 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| MX352307B (es) | 2011-02-01 | 2017-11-17 | Bayer Ip Gmbh | Derivados de heteroarilpiperidina y -piperazina como fungicidas. |
| BR112013020270A2 (pt) | 2011-02-10 | 2016-07-12 | Syngenta Participations Ag | derivados de pirazol microbicidas |
| CN103347879A (zh) | 2011-02-10 | 2013-10-09 | 先正达参股股份有限公司 | 杀微生物的吡唑衍生物 |
| CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| EP2755971B1 (de) | 2011-09-15 | 2017-12-20 | Bayer Intellectual Property GmbH | Piperidinpyrazole als fungizide |
| WO2013056911A1 (en) | 2011-10-18 | 2013-04-25 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
| WO2013056915A1 (en) | 2011-10-18 | 2013-04-25 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
| US8642774B2 (en) | 2011-12-08 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Compounds |
| US8889677B2 (en) | 2012-01-17 | 2014-11-18 | Boehringer Ingellheim International GmbH | Substituted triazoles useful as mGlu5 receptor modulators |
| CA2861231C (en) | 2012-01-25 | 2021-04-13 | Spinifex Pharmaceuticals Pty Ltd | Substituted 1-acyl-piperazine and 1-acyl-perhydro-1,4-diazepine compounds and their use as angiotensin ii type 2 receptor antagonists |
| CN104093715B (zh) * | 2012-02-02 | 2017-04-26 | 埃科特莱茵药品有限公司 | 4‑(苯并咪唑‑2‑基)‑噻唑化合物及相关氮杂衍生物 |
| EP2820015A1 (en) | 2012-03-02 | 2015-01-07 | Syngenta Participations AG | Microbiocidal pyrazole derivatives |
| EP2820012A1 (en) | 2012-03-02 | 2015-01-07 | Syngenta Participations AG | Microbiocidal pyrazole derivatives |
| NZ703448A (en) * | 2012-06-04 | 2017-07-28 | Actelion Pharmaceuticals Ltd | Benzimidazole-proline derivatives |
| WO2014062938A1 (en) | 2012-10-19 | 2014-04-24 | Bristol-Myers Squibb Company | Rory modulators |
| WO2014075874A1 (en) | 2012-11-13 | 2014-05-22 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
| WO2014075873A1 (en) | 2012-11-13 | 2014-05-22 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
| US9643957B2 (en) | 2012-12-11 | 2017-05-09 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds having cholesterol 24-hydroxylase activity |
| CN105473585B (zh) | 2013-06-24 | 2018-04-13 | 拜耳作物科学股份公司 | 作为杀真菌剂的哌啶羧酸衍生物 |
| EA030067B1 (ru) * | 2013-07-22 | 2018-06-29 | Идорсиа Фармасьютиклз Лтд | Производные 1-(пиперазин-1-ил)-2-([1,2,4]триазол-1-ил)этанона |
| WO2015026683A1 (en) | 2013-08-22 | 2015-02-26 | Merck Sharp & Dohme Corp. | Compounds inhibiting leucine-rich repeat kinase enzyme activity |
| AR099789A1 (es) | 2014-03-24 | 2016-08-17 | Actelion Pharmaceuticals Ltd | Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina |
| AR102256A1 (es) * | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi |
| AR103399A1 (es) * | 2015-01-15 | 2017-05-10 | Actelion Pharmaceuticals Ltd | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3 |
| AU2016207988B2 (en) * | 2015-01-15 | 2019-08-15 | Idorsia Pharmaceuticals Ltd | Hydroxyalkyl-piperazine derivatives as CXCR3 receptor modulators |
-
2016
- 2016-01-14 AU AU2016207988A patent/AU2016207988B2/en active Active
- 2016-01-14 MA MA041337A patent/MA41337A/fr unknown
- 2016-01-14 AR ARP160100086A patent/AR103414A1/es active IP Right Grant
- 2016-01-14 EP EP16700484.5A patent/EP3245203B1/en active Active
- 2016-01-14 CN CN201680005344.9A patent/CN107250133B/zh active Active
- 2016-01-14 TR TR2019/00680T patent/TR201900680T4/tr unknown
- 2016-01-14 US US15/543,457 patent/US10053457B2/en active Active
- 2016-01-14 HU HUE16700484A patent/HUE042559T2/hu unknown
- 2016-01-14 WO PCT/EP2016/050645 patent/WO2016113344A1/en active Application Filing
- 2016-01-14 PL PL16700484T patent/PL3245203T3/pl unknown
- 2016-01-14 RS RS20190186A patent/RS58349B1/sr unknown
- 2016-01-14 MX MX2017009288A patent/MX2017009288A/es active IP Right Grant
- 2016-01-14 NZ NZ734542A patent/NZ734542A/en unknown
- 2016-01-14 EA EA201791600A patent/EA032927B1/ru not_active IP Right Cessation
- 2016-01-14 BR BR112017015093-0A patent/BR112017015093A2/pt not_active Application Discontinuation
- 2016-01-14 ES ES16700484T patent/ES2709985T3/es active Active
- 2016-01-14 LT LTEP16700484.5T patent/LT3245203T/lt unknown
- 2016-01-14 DK DK16700484.5T patent/DK3245203T3/en active
- 2016-01-14 UA UAA201708224A patent/UA119805C2/uk unknown
- 2016-01-14 PE PE2017001213A patent/PE20171100A1/es unknown
- 2016-01-14 KR KR1020177022454A patent/KR101967083B1/ko active IP Right Grant
- 2016-01-14 SI SI201630179T patent/SI3245203T1/sl unknown
- 2016-01-14 PT PT16700484T patent/PT3245203T/pt unknown
- 2016-01-14 SG SG11201705617XA patent/SG11201705617XA/en unknown
- 2016-01-14 TN TNP/2017/000278A patent/TN2017000278A1/en unknown
- 2016-01-14 TW TW105101110A patent/TWI693221B/zh active
- 2016-01-14 JP JP2017555835A patent/JP6337218B2/ja active Active
- 2016-01-14 MY MYPI2017702534A patent/MY187614A/en unknown
- 2016-01-14 CA CA2972952A patent/CA2972952C/en active Active
-
2017
- 2017-07-11 IL IL253411A patent/IL253411B/en active IP Right Grant
- 2017-07-12 SA SA517381905A patent/SA517381905B1/ar unknown
- 2017-07-13 CL CL2017001831A patent/CL2017001831A1/es unknown
- 2017-07-13 PH PH12017501280A patent/PH12017501280B1/en unknown
- 2017-08-11 CO CONC2017/0008156A patent/CO2017008156A2/es unknown
- 2017-08-14 ZA ZA2017/05486A patent/ZA201705486B/en unknown
-
2018
- 2018-05-16 HK HK18106314.6A patent/HK1246789B/zh unknown
-
2019
- 2019-01-03 HR HRP20190024TT patent/HRP20190024T1/hr unknown
- 2019-01-30 CY CY20191100135T patent/CY1121361T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR103414A1 (es) | Derivados de hidroxialquil-piperazina como moduladores del receptor cxcr3 | |
| AR100645A1 (es) | Derivados de pirazolo-pirimidina | |
| AR106763A1 (es) | Oxadiazoles sustituidos para combatir hongos fitopatógenos | |
| AR117200A1 (es) | Derivados de tiazol microbiocidas | |
| AR100033A1 (es) | Compuestos y composiciones para inhibir la actividad de shp2 | |
| AR099995A1 (es) | Piridilamidinas fungicidas | |
| AR115662A2 (es) | Derivados de piperidina | |
| AR088226A1 (es) | Derivados piperidinicos heterociclicos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades neurodegenerativas | |
| MX2023011675A (es) | Beta-hidroxietilaminas heteroaril sustituidas para su uso en el tratamiento de hiperglucemia. | |
| AR094812A1 (es) | Derivado de piridina monocíclico como inhibidor del fgfr | |
| AR103138A1 (es) | Compuestos de heteroarilo como inhibidores de la irak y usos de los mismos | |
| AR099177A1 (es) | Determinadas (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1 | |
| AR098316A1 (es) | Derivados pirazolicos condensados, composiciones y métodos para modular los receptores x farnesoides | |
| AR094309A1 (es) | Compuesto heterociclico fusionado y uso del mismo para el control de plagas | |
| AR093020A1 (es) | Compuestos antiviricos para el vsr | |
| AR104884A1 (es) | Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj | |
| EA201591703A1 (ru) | Замещенные 2-азабициклы и их применение в качестве модуляторов рецепторов орексина | |
| AR080314A1 (es) | Derivado de 1,3,4,8-tetrahidro-2h-pirido (1,2-a) pirazina y su uso como inhibidor de la hiv integrasa | |
| AR099789A1 (es) | Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina | |
| AR111807A1 (es) | Derivados de benzofurano y benzotiofeno como moduladores del receptor pge2 | |
| AR097866A1 (es) | Derivados de 4-azaindol | |
| GT201400167A (es) | Nuevos derivados de bencil sulfonamida utiles como inhibidores de mogat-2 | |
| CY1119296T1 (el) | Ενωση δικαρβοξυλικου οξεος | |
| AR100327A1 (es) | Inhibidores de quinasa relacionados con tropomiosina | |
| AR097253A1 (es) | Derivado de pirazolilpirazol sustituido y el uso del mismo como herbicida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |